Tabula Rasa Healthcare PT Raised to $7 at RBC Capital, ''Preannounces Better-Than-Expected Q4'' 2023/01/17 21:35:02 Investing.com
Tabula Rasa HealthCare Announces Preliminary Estimated Fourth Quarter 2022 Revenues From Continuing Operations 2023/01/17 13:30:00 PR Newswire
Reports Preliminary Estimated Revenue from Continuing Operations of $82.0 - $83.0 Million for the Fourth Quarter of 2022, Continuing Strong 2022 Revenue Performance as Company Focuses on Core Business MOORESTOWN, N.J., Jan. 17, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. ("TRHC" or…
Tabula Rasa HealthCare Is Dead Money (NASDAQ:TRHC) 2022/12/20 12:58:07 Seeking Alpha
Tabula Rasa revenues keep rising, along with losses. I recommend braver souls than I buy call options in lieu of shares. Read more on TRHC stock here.
Tabula Rasa HealthCare, Inc. 2022 Q3 - Results - Earnings Call Presentation (NASDAQ:TRHC) 2022/12/06 18:22:31 Seeking Alpha
The following slide deck was published by Tabula Rasa HealthCare, Inc.
Tabula Rasa HealthCare, Inc. (TRHC) Q3 2022 Earnings Call Transcript 2022/11/04 20:24:04 Seeking Alpha
Tabula Rasa HealthCare, Inc. (NASDAQ:NASDAQ:TRHC) Q3 2022 Results Conference Call November 4, 2022 08:30 AM ET Company Participants Frank Sparacino - SVP, Investor Relations & Corporate…
Tabula Rasa HealthCare, Inc.''s (TRHC) CEO Calvin Knowlton on Q2 2022 Results -Earnings Call Transcript 2022/08/05 17:02:13 Seeking Alpha
Tabula Rasa HealthCare, Inc. (NASDAQ:NASDAQ:TRHC) Q2 2022 Earnings Conference Call August 5, 2022 8:30 A.M.
Tabula Rasa HealthCare Q2 results mixes, co raises FY 2022 revenue guidance 2022/08/04 20:36:26 Seeking Alpha
Tabula Rasa HealthCare press release (TRHC): Q2 GAAP EPS of -$2.07 misses by $1.26.Revenue of $72.6M (+12.9% Y/Y) beats by $3.73M.Sees FY 2022 total revenue from cont ops of $286M…
Tabula Rasa HealthCare Reports Second Quarter 2022 Results 2022/08/04 20:30:00 PR Newswire
Revenue from continuing operations of $72.6 million increased 13% vs. a year ago, driven by CareVention HealthCare revenue growth of 17%. GAAP net loss from continuing operations of $12.7 million vs. $14.1 million a year ago and $20.4 million in Q1 2022. Adjusted EBITDA from continuing…
Hedge Fund and Insider Trading News: Cathie Wood, Michael Burry, Ken Griffin, Point72 Asset Management, Cerberus Capital Management, Celina Hedgefond, Pantera Capital, Jefferies Financial Group Inc (JEF), Tabula Rasa HealthCare, Inc. (TRHC), and More 2022/07/27 17:24:43 Insider Monkey
New Breath of Life for Celina Hedgefond (Hedge Nordic) Stockholm (HedgeNordic) – Celina Hedgefond, once a €1.4 billion Catella fund whose portfolio maintains low enough risk to inspire comparisons to a bond investment, delivered a near zero return to investors over the six years ending 2021. Up 5.3 percent so far in 2022, the low-risk […]
Tabula Rasa, Trinity Health extend contract for CareKinesis PACE pharmacy services 2022/07/27 13:32:58 Seeking Alpha
Tabula Rasa HealthCare (TRHC) said a five-year contract was renewed with Trinity Health PACE for the company''s CareKinesis PACE Pharmacy services.Tabula said Trinity is a…
Why This Analyst Thinks Tabula Rasa''s Divestiture Plans ''An Important Step'' 2022/05/09 18:18:16 Benzinga
RBC Capital Markets believe that the market has been assigning little-to-no value to Tabula Rasa HealthCare Inc''s (NASDAQ: TRHC ) MedWise, which has been burning cash and clouding, a strong core PACE business. The analyst lowered the price target to $6 from $8, with an Outperform rating. Offloading MedWise should provide enough liquidity to fund operations, which RBC expects to happen sooner than anticipated. The management sounded confident the transaction(s) would close within the next quarter or … Full story available on Benzinga.com
4 Analysts Have This to Say About Tabula Rasa HealthCare 2022/05/09 14:12:12 Benzinga
Over the past 3 months, 4 analysts have published their opinion on Tabula Rasa HealthCare (NASDAQ: TRHC ) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company''s business to predict how a stock will trade over the upcoming year. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 1 2 0 0 Last 30D 0 1 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 0 1 0 0 In the last 3 months, 4 analysts have offered 12-month price targets for Tabula Rasa HealthCare. The company has an average price target of $9.0 with a high of $15.00 and a low of $4.00. Below is a summary of how these 4 analysts rated … Full story available on Benzinga.com
92 Biggest Movers From Friday 2022/05/09 10:27:28 Benzinga
Gainers Sidus Space, Inc. (NASDAQ: SIDU ) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the commercialization of space technologies and services. The Arena Group Holdings, Inc. (NYSE: AREN ) gained 43.5% to close at $15.00. Arena Group recently posted a Q1 loss of $1.20 per share. Nuvectis Pharma, Inc. (NASDAQ: NVCT ) jumped 30.2% to close at $18.20. Vinco Ventures, Inc. (NASDAQ: BBIG ) shares surged 28% to settle at $3.29. Vinco Ventures set record date as May 18, 2022 For dividend of shares related to Cryptyde deal. The dividend is expected to be distributed on May 27, 2022. Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC ) gained 27.3% to close at $4.10. Tabula Rasa HealthCare recently posted Q1 sales of $83.60 million. Funko, Inc. (NASDAQ: FNKO ) rose 26.9% to settle at $21.22 after The Chernin Group announced a consortium led by TCG will make a $263M strategic investment in Funko at $21 per share.
Tabula Rasa HealthCare''s (TRHC) CEO Calvin Knowlton on Q1 2022 Results -Earnings Call Transcript 2022/05/06 18:29:04 Seeking Alpha
Tabula Rasa HealthCare, Inc. (NASDAQ:NASDAQ:TRHC) Q1 2022 Earnings Conference Call May 6, 2022 8:30 AM ET Company Participants Kevin Dill – Corporate Counsel Calvin Knowlton – Founder,…